ネオゲンの収益は3. 4%減少し 期待を失くし 株式価格が低下した Neogen's revenue dropped 3.4%, missing expectations and causing its stock price to fall.

食品安全と動物健康の診断検査を行う会社であるネオゲンは 最近,売上高が3.4%減って2億2,100万ドルの見通しに 達しなかった. Neogen, a company that makes diagnostic tests for food safety and animal health, recently missed revenue expectations, reporting a 3.4% drop in sales to $221 million. 年間収入は8億9500万ドルと予想され,分析家の予測も満たされず,株価が下がった. Its full-year revenue guidance of $895 million also fell short of analysts' predictions, leading to a drop in its stock price. 2年分の収入増加率12.11%に満たないが,ネオゲンはこれまでの収益のピークに未だ戻っていない. Despite a two-year revenue growth of 12.1%, Neogen has not yet returned to its previous profitability peak.